AMERICAN INTERNATIONAL GROUP, INC. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$958,846
-18.1%
20,849
+2.3%
0.01%
-14.3%
Q2 2023$1,171,296
+49.7%
20,381
-2.3%
0.01%
+40.0%
Q1 2023$782,625
+34.5%
20,870
+0.5%
0.01%
+25.0%
Q4 2022$582,031
-1.2%
20,772
-1.0%
0.00%0.0%
Q3 2022$589,000
-18.2%
20,973
+1.3%
0.00%
-20.0%
Q2 2022$720,000
-5.4%
20,698
-2.3%
0.01%
+25.0%
Q1 2022$761,000
+45.2%
21,189
-5.8%
0.00%
+33.3%
Q4 2021$524,000
+18.6%
22,491
-3.2%
0.00%
+50.0%
Q3 2021$442,000
-8.7%
23,225
-3.2%
0.00%0.0%
Q2 2021$484,000
+8.8%
24,003
-1.1%
0.00%0.0%
Q1 2021$445,000
-9.9%
24,276
-1.1%
0.00%0.0%
Q4 2020$494,000
+4.7%
24,552
-2.4%
0.00%0.0%
Q3 2020$472,000
-15.7%
25,164
+1.0%
0.00%
-33.3%
Q2 2020$560,000
+53.8%
24,925
+1.6%
0.00%
+50.0%
Q1 2020$364,000
-26.8%
24,525
-4.8%
0.00%0.0%
Q4 2019$497,000
-5.2%
25,752
-2.6%
0.00%0.0%
Q3 2019$524,000
-7.4%
26,449
-1.4%
0.00%0.0%
Q2 2019$566,000
+4.6%
26,835
+1.3%
0.00%0.0%
Q1 2019$541,000
-1.1%
26,496
-3.6%
0.00%0.0%
Q4 2018$547,000
+2.2%
27,477
-1.2%
0.00%0.0%
Q3 2018$535,000
+27.7%
27,814
+1.4%
0.00%
+100.0%
Q2 2018$419,000
-3.7%
27,433
+18.3%
0.00%
-50.0%
Q1 2018$435,000
-21.3%
23,199
-19.3%
0.00%0.0%
Q4 2017$553,000
+8.0%
28,744
+0.3%
0.00%0.0%
Q3 2017$512,000
+5.8%
28,649
+5.7%
0.00%0.0%
Q2 2017$484,000
+52.2%
27,095
+23.7%
0.00%
+100.0%
Q1 2017$318,000
-33.9%
21,908
-16.2%
0.00%
-50.0%
Q4 2016$481,000
-99.9%
26,131
-1.0%
0.00%0.0%
Q3 2016$500,827,000
+51.6%
26,401
+28.9%
0.00%
+100.0%
Q2 2016$330,283,000
+48.1%
20,489
+10.1%
0.00%0.0%
Q1 2016$223,000,000
-15.8%
18,6070.0%0.00%0.0%
Q4 2015$265,000,000
+121459.6%
18,607
-0.2%
0.00%0.0%
Q3 2015$218,000
-99.9%
18,640
+0.1%
0.00%0.0%
Q2 2015$327,304,000
+276.6%
18,618
+220.5%
0.00%
Q1 2015$86,903,000
+28.9%
5,8090.0%0.00%
Q4 2014$67,442,0005,8090.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders